Press releasePRNewswire
Windtree Therapeutics
WINT · NASDAQ
$0.001+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.001
Latest news
- Press releaseGlobe Newswire
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
- Press releaseGlobe Newswire
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
- Press releaseGlobe Newswire
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption
- NewsMurtuza J Merchant
Why Are Public Companies Amassing ETH, XRP, SOL, BNB Instead Of Just Bitcoin?
- Press releaseGlobe Newswire
Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy
- Press releaseGlobe Newswire
Kraken and Windtree Therapeutics Announce Strategic Partnership for BNB Custody, Trading, and OTC Services
- NewsAvi Kapoor
Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings
- Press releaseGlobe Newswire
Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
- Press releaseGlobe Newswire
Windtree Announces Istaroxime Phase 2 Cardiogenic Shock Study Hits Enrollment Target for Planned Interim Analysis
- NewsAdam Eckert
Windtree Therapeutics Stock Is Volatile This Week: What's Going On?
- NewsDylan Berman
Windtree Stock Is Rising Tuesday: What's Going On?
- Press releaseBusiness Wire
Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
Windtree Therapeutics Q4 EPS $(4.63) Beats $(28.82) Estimate
- Press releaseGlobe Newswire
Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates
- Press releasePRNewswire
Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics
- NewsRishabh Mishra
US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert
- Press releasePRNewswire
Evofem Reports Fourth Consecutive Year of Net Sales Growth
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsVandana Singh
Windtree Therapeutics Heart Failure Drug Candidate Improves Systolic Blood Pressure
- NewsAvi Kapoor
Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
- NewsHenry Khederian
Why Windtree Therapeutics (WINT) Stock Is Volatile Today
- NewsAvi Kapoor
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
- NewsAvi Kapoor
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
- NewsAvi Kapoor
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
- NewsAvi Kapoor
Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5%
- NewsErica Kollmann
What's Going On With Windtree Therapeutics Stock?
- News
Market-Moving News for July 26th
- NewsAvi Kapoor
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.